BioSpace News Archive

Known as the Lone Star Bio Hotbed, Texas is home to multiple major players in the biopharma and biotech space and is currently a fast-growing hub for the life science industry.

Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the formation of its inaugural Clinical Development Advisory Board.

Immunome, Inc. today reported financial results for the second quarter ended June 30, 2022 and provided a corporate update.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that studies utilizing its portfolio of blood tests and real-world data will be presented at the IASLC 2022 World Conference on Lung Cancer (WCLC 2022), hosted by the International Association for the Study of Lung Cancer, August 6-9 in Vienna, Austria.

United BioPharma (UBP) today announced their latest results featuring unprecedented and unique functional characteristics of UB-221 monoclonal antibody in the phase I single-dose clinical trial, with chronic spontaneous urticaria (CSU) patients, to exhibit durable disease symptom relief.

PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, California.

Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease, announced that it will release its financial results for the second quarter 2022 after the close of trading on Thursday, August 11, 2022.

The global microfluidics market size reached USD 20.14 Billion in 2021 and is expected to register a revenue CAGR of 16.1% during the forecast period, according to latest analysis by Emergen Research.

Forecast to 2030,’ thoroughly examines the Anal Fistula Treatment industry to provide essential data & information for the targeted readers.

Forecast to 2030,’ thoroughly examines the Bullous Pemphigoid Treatment industry to provide essential data & information for the targeted readers.